Cargando…

Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers

Familial hypertrophic cardiomyopathy is an autosomal dominant genetic disease considered the most common cause of sudden cardiac death in individuals under 35 years old, especially the athletes. This study aimed to investigate the association between the presence of late potentials and a family hist...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaves-Markman, Ândrea, Markman, Manuel, Santos-Veloso, Marcelo Antônio O, Bezerra, Lucas S, Sobral Filho, Dário C, Markman Filho, Brivaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996270/
https://www.ncbi.nlm.nih.gov/pubmed/32042515
http://dx.doi.org/10.7759/cureus.6530
_version_ 1783493496025382912
author Chaves-Markman, Ândrea
Markman, Manuel
Santos-Veloso, Marcelo Antônio O
Bezerra, Lucas S
Sobral Filho, Dário C
Markman Filho, Brivaldo
author_facet Chaves-Markman, Ândrea
Markman, Manuel
Santos-Veloso, Marcelo Antônio O
Bezerra, Lucas S
Sobral Filho, Dário C
Markman Filho, Brivaldo
author_sort Chaves-Markman, Ândrea
collection PubMed
description Familial hypertrophic cardiomyopathy is an autosomal dominant genetic disease considered the most common cause of sudden cardiac death in individuals under 35 years old, especially the athletes. This study aimed to investigate the association between the presence of late potentials and a family history of sudden death, syncope, and complex ventricular arrhythmias on patients with hypertrophic cardiomyopathy. A case series study was carried out from March 2001 to December 2002, including 22 patients with hypertrophic cardiomyopathy according to transthoracic echocardiogram criteria. Patients on a cardiac pacemaker, right bundle branch block, cardiac transplant, and under no possibilities to realize the exams were excluded. The results showed that asymmetric septal hypertrophy was the most common type (73%), 63% had a positive familial history of hypertrophic cardiomyopathy, 55% sudden cardiac death, and 23% syncope. Also, complex ventricular arrhythmias were detected in 14% and late potentials in 23% of patients. According to this study, the presence of late potentials was not associated with familial sudden death, syncope, and complex ventricular arrhythmias.
format Online
Article
Text
id pubmed-6996270
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-69962702020-02-10 Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers Chaves-Markman, Ândrea Markman, Manuel Santos-Veloso, Marcelo Antônio O Bezerra, Lucas S Sobral Filho, Dário C Markman Filho, Brivaldo Cureus Cardiology Familial hypertrophic cardiomyopathy is an autosomal dominant genetic disease considered the most common cause of sudden cardiac death in individuals under 35 years old, especially the athletes. This study aimed to investigate the association between the presence of late potentials and a family history of sudden death, syncope, and complex ventricular arrhythmias on patients with hypertrophic cardiomyopathy. A case series study was carried out from March 2001 to December 2002, including 22 patients with hypertrophic cardiomyopathy according to transthoracic echocardiogram criteria. Patients on a cardiac pacemaker, right bundle branch block, cardiac transplant, and under no possibilities to realize the exams were excluded. The results showed that asymmetric septal hypertrophy was the most common type (73%), 63% had a positive familial history of hypertrophic cardiomyopathy, 55% sudden cardiac death, and 23% syncope. Also, complex ventricular arrhythmias were detected in 14% and late potentials in 23% of patients. According to this study, the presence of late potentials was not associated with familial sudden death, syncope, and complex ventricular arrhythmias. Cureus 2020-01-01 /pmc/articles/PMC6996270/ /pubmed/32042515 http://dx.doi.org/10.7759/cureus.6530 Text en Copyright © 2020, Chaves-Markman et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Chaves-Markman, Ândrea
Markman, Manuel
Santos-Veloso, Marcelo Antônio O
Bezerra, Lucas S
Sobral Filho, Dário C
Markman Filho, Brivaldo
Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers
title Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers
title_full Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers
title_fullStr Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers
title_full_unstemmed Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers
title_short Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers
title_sort familial hypertrophic cardiomyopathy: late potentials and other prognostic markers
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996270/
https://www.ncbi.nlm.nih.gov/pubmed/32042515
http://dx.doi.org/10.7759/cureus.6530
work_keys_str_mv AT chavesmarkmanandrea familialhypertrophiccardiomyopathylatepotentialsandotherprognosticmarkers
AT markmanmanuel familialhypertrophiccardiomyopathylatepotentialsandotherprognosticmarkers
AT santosvelosomarceloantonioo familialhypertrophiccardiomyopathylatepotentialsandotherprognosticmarkers
AT bezerralucass familialhypertrophiccardiomyopathylatepotentialsandotherprognosticmarkers
AT sobralfilhodarioc familialhypertrophiccardiomyopathylatepotentialsandotherprognosticmarkers
AT markmanfilhobrivaldo familialhypertrophiccardiomyopathylatepotentialsandotherprognosticmarkers